Zurcher Kantonalbank Zurich Cantonalbank Has $65.10 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Zurcher Kantonalbank Zurich Cantonalbank cut its holdings in Encompass Health Co. (NYSE:EHC) by 3.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 673,628 shares of the company’s stock after selling 26,969 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Encompass Health were worth $65,099,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. UMB Bank n.a. grew its position in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares in the last quarter. V Square Quantitative Management LLC grew its position in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new position in Encompass Health during the 3rd quarter worth $40,000. Oakworth Capital Inc. acquired a new position in Encompass Health in the 2nd quarter valued at $40,000. Finally, Benjamin F. Edwards & Company Inc. lifted its position in shares of Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares during the period. 97.25% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on EHC shares. UBS Group boosted their price target on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Royal Bank of Canada boosted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Stephens reissued an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a research note on Tuesday, August 6th. Finally, KeyCorp boosted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Down 0.9 %

NYSE:EHC opened at $102.84 on Thursday. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market cap of $10.36 billion, a PE ratio of 24.84, a P/E/G ratio of 1.35 and a beta of 0.88. The firm’s 50 day simple moving average is $97.53 and its 200 day simple moving average is $91.11.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health’s revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.86 earnings per share. On average, research analysts anticipate that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s payout ratio is 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.